BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Deals

  Medigene Sells U.S.-Rights for Veregen and Raises Financial Guidance 2017

  MediGene today announced the sale of the US-rights for its drug Veregen to Fougera Pharma.

  December 6, 2017

   · 

  3 min read
• Myriad Genetics Presents Pivotal Validation Study for New riskScore Test at the 2017 San Antonio Breast Cancer Symposium

  Myriad Genetics today announced results from a ground-breaking validation study to better define the risk of breast cancer in women of European ancestry who test negative for a hereditary cancer mutation with the myRisk Hereditary Cancer test.

  December 6, 2017

   · 

  9 min read
• Pharm Country

  O’Brien Medical Launches New Instrument for Diabetes Market

  Now clinicians can implement a standardized approach for diagnosing diabetic peripheral neuropathy utilizing the three most popular frequencies in medicine.

  December 6, 2017

   · 

  1 min read
• Drug Development

  Minerva Neurosciences Announces Enrollment of First Patient in Phase IIb Trial of Seltorexant (MIN-202) in Patients With Insomnia Disorder

  The primary objective of this trial is to assess the dose-response of three doses of seltorexant compared to placebo on sleep onset as measured by the latency to persistent sleep using polysomnography.

  December 6, 2017

   · 

  4 min read
• Robocath Raises a Total of €6.4 Million ($7.6M) in 2017

  This latest financial contribution supplements the $5.6M raised by Robocath in a previous round of fundraising in May.

  December 6, 2017

   · 

  4 min read
• Business

  Neumentum Raises $6 Million in Series A Funding to Develop Non-opioid Pain Products and Requests Type B Meeting with FDA

  Neumentum announced that it has raised $6 million in a Series A funding round through the sale of Series A Convertible Preferred Stock. Brookline Capital Markets acted as the exclusive placement agent for the financing.

  December 6, 2017

   · 

  5 min read
• Business

  ADC Bio Signs Construction Agreement With Sector Specialists WHP

  The new facilities will provide much needed capacity to its global ADC clients from its newly acquired Deeside facility, which is planned to be operational in September 2018.

  December 6, 2017

   · 

  2 min read
• Deals

  Zynex Announces Share Buyback Program

  Zynex today announced that its board of directors approved a program to buy back up to $2M of the Company’s common stock.

  December 6, 2017

   · 

  2 min read
• Biomed X Launches New Conference Format XSEED CON 2018 - Towards Next Generation Bioscience

  For the first time in the successful history of the BioMed X Innovation Center in Heidelberg, its new model based on global crowdsourcing and local incubation of the brightest ideas and talents will now be exposed to a wider audience.

  December 6, 2017

   · 

  3 min read
• Business

  Nosopharm Bolsters Supervisory Board

  Alberici will be Nosopharm’s new chairman.

  December 6, 2017

   · 

  4 min read